Timothy W Corson Selected Research

5,7- dihydroxy- 3- (3- hydroxy- 4- methoxybenzyl)- 6- methoxychroman- 4- one

6/2015	Synthesis and Biological Evaluation of Novel Homoisoflavonoids for Retinal Neovascularization.
10/2014	The first synthesis of the antiangiogenic homoisoflavanone, cremastranone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy W Corson Research Topics

Disease

22	Neoplasms (Cancer) 01/2024 - 09/2004
15	Retinoblastoma (Glioblastoma, Retinal) 03/2020 - 09/2004
13	Choroidal Neovascularization 11/2023 - 12/2014
6	Eye Diseases (Eye Disease) 01/2023 - 01/2014
5	Inflammation (Inflammations) 01/2023 - 01/2014
5	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 01/2018
4	Vascular Diseases (Vascular Disease) 01/2021 - 01/2019
3	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2021 - 01/2019
3	Neoplasm Metastasis (Metastasis) 12/2014 - 09/2004
3	Breast Neoplasms (Breast Cancer) 03/2014 - 07/2005
2	Retinal Neovascularization 10/2022 - 01/2020
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 09/2021 - 01/2019
2	Toxic Optic Neuropathy 01/2020 - 01/2016
2	Pathologic Neovascularization 10/2014 - 01/2014
2	Carcinogenesis 03/2014 - 07/2005
1	Retinal Diseases 01/2023
1	Adenocarcinoma 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Macular Edema 01/2021
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 08/2020
1	Uveal melanoma 03/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Retinal Neoplasms 10/2016
1	Oculocerebrorenal Syndrome (Lowe Syndrome) 09/2014
1	Triple Negative Breast Neoplasms 03/2014
1	Kidney Diseases (Kidney Disease) 07/2011
1	Lymphoma (Lymphomas) 02/2011
1	Major Depressive Disorder (Major Depressive Disorders) 02/2011
1	Bipolar Disorder (Manic Depressive Psychosis) 02/2011
1	Aneuploidy (Aneuploid) 05/2008
1	Genomic Instability 05/2008
1	Lung Neoplasms (Lung Cancer) 06/2007
1	Carcinoma (Carcinomatosis) 06/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2007
1	Ductal Carcinoma 09/2006

Drug/Important Bio-Agent (IBA)

16	Retinaldehyde (Retinal)IBA 09/2021 - 09/2004
13	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2004
6	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2014
6	KinesinsIBA 11/2018 - 09/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2014
5	Messenger RNA (mRNA)IBA 01/2014 - 09/2004
4	Ferrochelatase (Heme Synthetase)IBA 11/2023 - 01/2017
4	Heme (Haem)IBA 01/2021 - 01/2017
4	Tumor Viral Antigens (Large T Antigen)IBA 10/2016 - 09/2004
3	EnzymesIBA 11/2023 - 01/2017
3	Griseofulvin (Grifulvin V)FDA LinkGeneric 11/2023 - 01/2017
3	Epoxide HydrolasesIBA 01/2023 - 01/2019
2	SH-11037IBA 10/2022 - 01/2016
2	5,7- dihydroxy- 3- (3- hydroxy- 4- methoxybenzyl)- 6- methoxychroman- 4- oneIBA 06/2015 - 10/2014
2	Estrogen ReceptorsIBA 03/2014 - 09/2006
2	MicroRNAs (MicroRNA)IBA 01/2014 - 07/2007
2	osteoblast cadherinIBA 09/2011 - 09/2004
1	Nucleic AcidsIBA 01/2024
1	PolymersIBA 11/2023
1	Polyglactin 910IBA 11/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	PterocarpansIBA 01/2023
1	Neuroprotective AgentsIBA 09/2021
1	CytokinesIBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 03/2020
1	Small Molecule LibrariesIBA 01/2020
1	HydrolasesIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	RutheniumIBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Nonsense Codon (Nonsense Mutation)IBA 07/2016
1	Aligeron (AS 2)IBA 01/2015
1	Chalcone (Benzalacetophenone)IBA 12/2014
1	isoliquiritigenin (GU 17)IBA 12/2014
1	CurcuminIBA 12/2014
1	Inositol Polyphosphate 5-PhosphatasesIBA 09/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2014
1	ErbB Receptors (EGF Receptor)IBA 03/2014
1	Docetaxel (Taxotere)FDA Link 03/2014
1	Biomarkers (Surrogate Marker)IBA 03/2014
1	LuciferinsIBA 01/2014
1	LuciferasesIBA 01/2014
1	enhanced green fluorescent proteinIBA 01/2014
1	Complement System Proteins (Complement)IBA 01/2014
1	Phosphotransferases (Kinase)IBA 05/2012
1	Carbonic Anhydrase IIIBA 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 09/2011
1	triptolideIBA 07/2011
1	Apoptosis Regulatory ProteinsIBA 02/2011
1	CalciumIBA 02/2011
1	N 30IBA 02/2011
1	Cyclin-Dependent Kinase Inhibitor p16IBA 05/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2007
1	AgarIBA 06/2007
1	RNA (Ribonucleic Acid)IBA 06/2007
1	Indicators and Reagents (Reagents)IBA 07/2005
1	chromokinesinIBA 07/2005

Therapy/Procedure

10	Therapeutics 01/2022 - 11/2012
5	Lasers (Laser) 01/2023 - 10/2015
2	Intravitreal Injections 09/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 03/2014 - 02/2007
1	Aftercare (After-Treatment) 01/2024
1	Biological Therapy 01/2014
1	Long-Term Care 04/2013